HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Identification of novel ATP13A2 interactors and their role in α-synuclein misfolding and toxicity.

Abstract
Lysosomes are responsible for degradation and recycling of bulky cell material, including accumulated misfolded proteins and dysfunctional organelles. Increasing evidence implicates lysosomal dysfunction in several neurodegenerative disorders, including Parkinson's disease and related synucleinopathies, which are characterized by the accumulation of α-synuclein (α-syn) in Lewy bodies. Studies of lysosomal proteins linked to neurodegenerative disorders present an opportunity to uncover specific molecular mechanisms and pathways that contribute to neurodegeneration. Loss-of-function mutations in a lysosomal protein, ATP13A2 (PARK9), cause Kufor-Rakeb syndrome that is characterized by early-onset parkinsonism, pyramidal degeneration and dementia. While loss of ATP13A2 function plays a role in α-syn misfolding and toxicity, the normal function of ATP13A2 in the brain remains largely unknown. Here, we performed a screen to identify ATP13A2 interacting partners, as a first step toward elucidating its function. Utilizing a split-ubiquitin membrane yeast two-hybrid system that was developed to identify interacting partners of full-length integral membrane proteins, we identified 43 novel interactors that primarily implicate ATP13A2 in cellular processes such as endoplasmic reticulum (ER) translocation, ER-to-Golgi trafficking and vesicular transport and fusion. We showed that a subset of these interactors modified α-syn aggregation and α-syn-mediated degeneration of dopaminergic neurons in Caenorhabditis elegans, further suggesting that ATP13A2 and α-syn are functionally linked in neurodegeneration. These results implicate ATP13A2 in vesicular trafficking and provide a platform for further studies of ATP13A2 in neurodegeneration.
AuthorsMarija Usenovic, Adam L Knight, Arpita Ray, Victoria Wong, Kevin R Brown, Guy A Caldwell, Kim A Caldwell, Igor Stagljar, Dimitri Krainc
JournalHuman molecular genetics (Hum Mol Genet) Vol. 21 Issue 17 Pg. 3785-94 (Sep 01 2012) ISSN: 1460-2083 [Electronic] England
PMID22645275 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • ATP13A2 protein, human
  • alpha-Synuclein
  • Proton-Translocating ATPases
Topics
  • Animals
  • Caenorhabditis elegans (drug effects, metabolism)
  • Dopaminergic Neurons (drug effects, metabolism, pathology)
  • Gene Knockdown Techniques
  • HEK293 Cells
  • Humans
  • Nerve Degeneration (metabolism, pathology)
  • Protein Binding (drug effects)
  • Protein Folding (drug effects)
  • Proton-Translocating ATPases (metabolism)
  • Reproducibility of Results
  • Two-Hybrid System Techniques
  • alpha-Synuclein (chemistry, metabolism, toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: